← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 31, 2020Last known activity
Aug 23, 2024
Timeline
2010s
- Jun 1, 2016
BlueSky Immunotherapies GmbH— Founded
Drugs by trial phase (1 distinct, 3 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06589609Lead sponsorPhase 1Aug 23, 2024
- NCT05829629Lead sponsorPhase 1Sep 12, 2023
- NCT04490512Lead sponsorPhase 1Aug 31, 2020
Details
- Founded
- Vienna, AT Jun 1, 2016
- Last known activity
- Aug 23, 2024